Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Sino Medical Sciences Technology Inc.
  6. Company
    688108   CNE100003NY2

SINO MEDICAL SCIENCES TECHNOLOGY INC.

(688108)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Sino Medical Sciences Technology Inc. is a China-based company mainly engaged in the research, development, production and sales of high-end interventional medical devices. The Company's product pipeline covers the field of interventional therapy such as cardiovascular, cerebrovascular, and structural heart disease. The Company's main products include coronary stent systems and balloon dilatation catheters. The Company conducts its businesses within the domestic market and to overseas markets.

Number of employees : 527 people.
Sales per Business
20192020Delta
Bracket366.5684.9%226.4569.9% -38.22%
Balloon67.7015.7%99.6830.8% +47.25%
Other Business1.610.4%1.170.4% -27.19%
Other0.050%0.110% +132.43%
CNY in Million
Sales per region
20192020Delta
China427.6999%323.2599.8% -24.42%
Overseas6.621.5%3.000.9% -54.68%
CNY in Million
Managers
Name Title Age Since
Jian Hua Sun, Dr. Chairman & General Manager 60 2007
Li Hua Shen Chief Financial Officer & Director 49 2013
Chang Chun Yu, Dr. Independent Director 69 2018
Rui Li, Dr. Independent Director 43 2020
Yan Gao, Dr. Independent Director 55 2020
Xidan Zhang Securities Representative - 2021
Kai Huang Secretary & Director 48 2016
Xiang Fei Miao Sales Manager - 2009
Li Ye Cui Director & Deputy General Manager 47 -
Members of the board
Name Title Age Since
Jian Hua Sun, Dr. Chairman & General Manager 60 2007
Li Ye Cui Director & Deputy General Manager 47 -
Kai Huang Secretary & Director 48 2016
Xiao Ran Kang Director 35 2009
Chang Chun Yu, Dr. Independent Director 69 2018
Li Hua Shen Chief Financial Officer & Director 49 2013
Wen Bin Cai Member-Supervisory Board 37 2007
Tian Zhu Li Member-Supervisory Board 38 2007
Rui Li, Dr. Independent Director 43 2020
Lin Chen Director 39 2021
Shareholders
NameEquities%
New Horizon Advisors (HK) Ltd. 54,717,378 19.0%
Wei Xu 26,903,823 9.36%
China Renaissance Capital Investment, Inc. 24,478,395 8.52%
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. 18,403,866 6.40%
Decheng Capital LLC 16,407,575 5.71%
Champ Star Technology Ltd. 10,093,669 3.51%
Beijing Runxin Zhongan Investment Management Co. Ltd. 9,642,854 3.36%
Fullgoal Fund Management Co., Ltd. 1,844,700 0.64%
Wanjia Asset Management Co., Ltd. 1,839,612 0.64%
China Asset Management Co., Ltd. 300,749 0.10%
Company contact information
Sino Medical Sciences Technology, Inc.
2/F, TEDA Bio Res & Dev Bldg B
5 Fourth Avenue
Economic & Technological Dev Zone
Tianjin 300457

Phone : +86.22.5986.2999
Fax : +22.6200.0060
Web : http://www.sinomedical.net
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sino Medical Sciences Technology Inc.